APA (7th ed.) Citation

RR, M., N, C., JA, L., PP, S., M, M., J, H., . . . AK, O. (2026). N‑Alkyl and N‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors. ACS medicinal chemistry letters, 17(3), 744. https://doi.org/10.1021/acsmedchemlett.6c00066

Chicago Style (17th ed.) Citation

RR, Merchant, et al. "N‑Alkyl and N‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors." ACS Medicinal Chemistry Letters 17, no. 3 (2026): 744. https://doi.org/10.1021/acsmedchemlett.6c00066.

MLA (9th ed.) Citation

RR, Merchant, et al. "N‑Alkyl and N‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors." ACS Medicinal Chemistry Letters, vol. 17, no. 3, 2026, p. 744, https://doi.org/10.1021/acsmedchemlett.6c00066.